Exogenous Schwann Cells Migrate, Remyelinate and Promote Clinical Recovery in Experimental Auto-Immune Encephalomyelitis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Zujovic, Violetta ^a,b,c   Doucerain, Cédric ^a,b,c   Hidalgo, Antoine ^a,b,c   Bachelin, Corinne ^a,b,c   Lachapelle, François ^a,b,c   Weissert, Robert ^e   Stadelmann, Christine ^f   Linington, Chris ^g   Evercooren, Anne Baron Van ^a,b,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f Institut fur Neuropathologie   (Germany)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL FATE; CELL INTERACTION; CELL MIGRATION; CELL SURVIVAL; CELL TRANSPLANTATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; FEMALE; IMMUNOREACTIVITY; NONHUMAN; PARENCHYMA; PROTEIN EXPRESSION; RAT; REMYELINIZATION; SCHWANN CELL; SURVIVAL RATE;

ANIMALS; ASTROCYTES; CELL MOVEMENT; CELL SURVIVAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GREEN FLUORESCENT PROTEINS; INJECTIONS, SPINAL; MYELIN SHEATH; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; RATS; RECOVERY OF FUNCTION; SCHWANN CELLS; SPINAL CORD; TRANSDUCTION, GENETIC;

AGOUTI; ANIMALIA; RATTUS;

EID: 84866298285     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042667     Document Type: Article

References (49)

1. Martino G, Franklin RJ, Van Evercooren AB, Kerr DA, (2010) Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol 6: 247-255.
2. Wood PM, (1976) Separation of functional Schwann cells and neurons from normal peripheral nerve tissue. Brain Res 115: 361-375.
3. Brockes JP, Fields KL, Raff MC, (1979) Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165: 105-118.
4. Rutkowski JL, Kirk CJ, Lerner MA, Tennekoon GI, (1995) Purification and expansion of human Schwann cells in vitro. Nat Med 1: 80-83.
5. Avellana-Adalid V, Bachelin C, Lachapelle F, Escriou C, Ratzkin B, et al. (1998) In vitro and in vivo behaviour of NDF-expanded monkey Schwann cells. Eur J Neurosci 10: 291-300.
6. Zujovic V, Bachelin C, Baron-Van Evercooren A, (2007) Remyelination of the central nervous system: a valuable contribution from the periphery. Neuroscientist 13: 383-391.
7. Honmou O, Felts PA, Waxman SG, Kocsis JD, (1996) Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. J Neurosci 16: 3199-3208.
8. Girard C, Bemelmans AP, Dufour N, Mallet J, Bachelin C, et al. (2005) Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci 25: 7924-7933.
9. Bachelin C, Lachapelle F, Girard C, Moissonnier P, Serguera-Lagache C, et al. (2005) Efficient myelin repair in the macaque spinal cord by autologous grafts of Schwann cells. Brain 128: 540-549.
10. Feigin I, Ogata J, (1971) Schwann cells and peripheral myelin within human central nervous tissues: the mesenchymal character of Schwann cells. J Neuropathol Exp Neurol 30: 603-612.
11. Prineas JW, Connell F, (1979) Remyelination in multiple sclerosis. Ann Neurol 5: 22-31.
12. Itoyama Y, Webster HD, Richardson EP, Trapp BD, (1983) Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol 14: 339-346.
13. Yamamoto T, Kawamura J, Hashimoto S, Nakamura M, (1991) Extensive proliferation of peripheral type myelin in necrotic spinal cord lesions of multiple sclerosis. J Neurol Sci 102: 163-169.
14. Woodhoo A, Sahni V, Gilson J, Setzu A, Franklin RJ, et al. (2007) Schwann cell precursors: a favourable cell for myelin repair in the Central Nervous System. Brain 130: 2175-2185.
15. Zujovic V, Thibaud J, Bachelin C, Vidal M, Coulpier F, et al. (2010) Boundary cap cells are highly competitive for CNS remyelination: fast migration and efficient differentiation in PNS and CNS myelin-forming cells. Stem Cells 28: 470-479.
16. Fernandes KJ, McKenzie IA, Mill P, Smith KM, Akhavan M, et al. (2004) A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 6: 1082-1093.
17. Fernandes KJ, Kobayashi NR, Gallagher CJ, Barnabe-Heider F, Aumont A, et al. (2006) Analysis of the neurogenic potential of multipotent skin-derived precursors. Exp Neurol 201: 32-48.
18. Toma JG, McKenzie IA, Bagli D, Miller FD, (2005) Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23: 727-737.
19. Sieber-Blum M, Grim M, Hu YF, Szeder V, (2004) Pluripotent neural crest stem cells in the adult hair follicle. Dev Dyn 231: 258-269.
20. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, et al. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27: 275-280.
21. Lee G, Chambers SM, Tomishima MJ, Studer L, (2010) Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc 5: 688-701.
22. Menendez L, Yatskievych TA, Antin PB, Dalton S, (2011) Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells. Proc Natl Acad Sci U S A 108: 19240-19245.
23. Wang A, Tang Z, Park IH, Zhu Y, Patel S, et al. (2011) Induced pluripotent stem cells for neural tissue engineering. Biomaterials 32: 5023-5032.
24. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, et al. (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8: 681-694.
25. Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, et al. (2002) The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J Neurocytol 31: 523-536.
26. Gold R, Linington C, Lassmann H, (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953-1971.
27. Franklin RJ, Blakemore WF, (1993) Requirements for Schwann cell migration within CNS environments: a viewpoint. Int J Dev Neurosci 11: 641-649.
28. Bachelin C, Zujovic V, Buchet D, Mallet J, Baron-Van Evercooren A, (2010) Ectopic expression of polysialylated neural cell adhesion molecule in adult macaque Schwann cells promotes their migration and remyelination potential in the central nervous system. Brain 133: 406-420.
29. Baron-Van Evercooren A, Gansmuller A, Duhamel E, Pascal F, Gumpel M, (1992) Repair of a myelin lesion by Schwann cells transplanted in the adult mouse spinal cord. J Neuroimmunol 40: 235-242.
30. Shields SA, Blakemore WF, Franklin RJ, (2000) Schwann cell remyelination is restricted to astrocyte-deficient areas after transplantation into demyelinated adult rat brain. J Neurosci Res 60: 571-578.
31. Kaneko S, Iwanami A, Nakamura M, Kishino A, Kikuchi K, et al. (2006) A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med 12: 1380-1389.
32. Fairless R, Frame MC, Barnett SC, (2005) N-cadherin differentially determines Schwann cell and olfactory ensheathing cell adhesion and migration responses upon contact with astrocytes. Mol Cell Neurosci 28: 253-263.
33. Santos-Silva A, Fairless R, Frame MC, Montague P, Smith GM, et al. (2007) FGF/heparin differentially regulates Schwann cell and olfactory ensheathing cell interactions with astrocytes: a role in astrocytosis. J Neurosci 27: 7154-7167.
34. Afshari FT, Kwok JC, Fawcett JW, (2010) Astrocyte-produced ephrins inhibit schwann cell migration via VAV2 signaling. J Neurosci 30: 4246-4255.
35. Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, et al. (2003) Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422: 688-694.
36. Mueller AM, Pedre X, Stempfl T, Kleiter I, Couillard-Despres S, et al. (2008) Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis. J Neuroinflammation 5: 20.
37. Rosner BI, Hang T, Tranquillo RT, (2005) Schwann cell behavior in three-dimensional collagen gels: evidence for differential mechano-transduction and the influence of TGF-beta 1 in morphological polarization and differentiation. Exp Neurol 195: 81-91.
38. Jessen KR, Mirsky R, (2002) Signals that determine Schwann cell identity. J Anat 200: 367-376.
39. Patel JR, McCandless EE, Dorsey D, Klein RS, (2010) CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci U S A 107: 11062-11067.
40. Pereira JA, Baumann R, Norrmen C, Somandin C, Miehe M, et al. (2010) Dicer in Schwann cells is required for myelination and axonal integrity. J Neurosci 30: 6763-6775.
41. Meiron M, Zohar Y, Anunu R, Wildbaum G, Karin N, (2008) CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J Exp Med 205: 2643-2655.
42. Moll NM, Cossoy MB, Fisher E, Staugaitis SM, Tucky BH, et al. (2009) Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch Neurol 66: 44-53.
43. Odemis V, Boosmann K, Heinen A, Kury P, Engele J, (2010) CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J Cell Sci 123: 1081-1088.
44. Opatz J, Kury P, Schiwy N, Jarve A, Estrada V, et al. (2009) SDF-1 stimulates neurite growth on inhibitory CNS myelin. Mol Cell Neurosci 40: 293-300.
45. Lavdas AA, Papastefanaki F, Thomaidou D, Matsas R, (2008) Schwann cell transplantation for CNS repair. Curr Med Chem 15: 151-160.
46. Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, et al. (2005) Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436: 266-271.
47. Einstein O, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Polyzoidou E, et al. (2006) Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 198: 275-284.
48. Wohlleben G, Ibrahim SM, Schmidt J, Toyka KV, Hartung HP, et al. (2000) Regulation of Fas and FasL expression on rat Schwann cells. Glia 30: 373-381.
49. Mimouni-Rongy M, White JH, Weinstein DE, Desbarats J, Almazan G, (2011) Fas ligand acts as a counter-receptor in Schwann cells and induces the secretion of bioactive nerve growth factor. J Neuroimmunol 230: 17-25.